Stage IIIC1 Cervical Cancer FIGO 2018
4 clinical trials · Condition
◉ Watch Stage IIIC1 Cervical Cancer FIGO 2018
| Record | Firm | Date |
|---|---|---|
| Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer (NCT07061977) | National Cancer Institute (NCI) | 2025-11-05 |
| Patient-Informed Educational Intervention for the Improvement of Cervical Cancer Literacy (NCT05093712) | M.D. Anderson Cancer Center | 2021-06-28 |
| Human Papilloma Virus (HPV) Circulating Tumor DNA (ctDNA) in Cervical Cancer (NCT04574635) | Mayo Clinic | 2020-11-17 |
| A Vaccine (PDS0101) and Chemoradiation for the Treatment of Stage IB3-IVA Cervical Cancer, the IMMUNOCERV Trial (NCT04580771) | M.D. Anderson Cancer Center | 2020-10-14 |
Track Stage IIIC1 Cervical Cancer FIGO 2018 automatically
Every clearance here is in the API, with alerts when new ones post.